Global Infusion Therapies and Technology Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Infusion Therapies and Technology market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Infusion Therapies and Technology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Infusion Therapies and Technology market size and forecasts, in consumption value ($ Million), 2021-2032
Global Infusion Therapies and Technology market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Infusion Therapies and Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Infusion Therapies and Technology market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infusion Therapies and Technology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infusion Therapies and Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter Healthcare, Kelun Group, Fresenius, B. Braun, Ostuka Pharmaceutical, ICU Medical, SSY Group, Shuang Hor, Cisen Pharmaceutical, PiSA Farmac?utica, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Infusion Therapies and Technology market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Infusion Therapies and Technology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infusion Therapies and Technology, with revenue, gross margin, and global market share of Infusion Therapies and Technology from 2021 to 2026.
Chapter 3, the Infusion Therapies and Technology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Infusion Therapies and Technology market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infusion Therapies and Technology.
Chapter 13, to describe Infusion Therapies and Technology research findings and conclusion.
This report is a detailed and comprehensive analysis for global Infusion Therapies and Technology market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Infusion Therapies and Technology market size and forecasts, in consumption value ($ Million), 2021-2032
Global Infusion Therapies and Technology market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Infusion Therapies and Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Infusion Therapies and Technology market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infusion Therapies and Technology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infusion Therapies and Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter Healthcare, Kelun Group, Fresenius, B. Braun, Ostuka Pharmaceutical, ICU Medical, SSY Group, Shuang Hor, Cisen Pharmaceutical, PiSA Farmac?utica, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Infusion Therapies and Technology market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Large Volume Intravenous Infusion
- Small Volume Intravenous Infusion
- Basic Infusion
- Therapeutic Infusion
- Nutritious Infusion
- Baxter Healthcare
- Kelun Group
- Fresenius
- B. Braun
- Ostuka Pharmaceutical
- ICU Medical
- SSY Group
- Shuang Hor
- Cisen Pharmaceutical
- PiSA Farmac?utica
- Huaren Pharmaceutical
- Chimin
- Beximco Pharma
- Albert David
- PSI Ltd
- Ozon Pharmaceuticals
- BML Parenteral Drugs
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Infusion Therapies and Technology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infusion Therapies and Technology, with revenue, gross margin, and global market share of Infusion Therapies and Technology from 2021 to 2026.
Chapter 3, the Infusion Therapies and Technology competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Infusion Therapies and Technology market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infusion Therapies and Technology.
Chapter 13, to describe Infusion Therapies and Technology research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Infusion Therapies and Technology by Type
1.3.1 Overview: Global Infusion Therapies and Technology Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Infusion Therapies and Technology Consumption Value Market Share by Type in 2025
1.3.3 Large Volume Intravenous Infusion
1.3.4 Small Volume Intravenous Infusion
1.4 Global Infusion Therapies and Technology Market by Application
1.4.1 Overview: Global Infusion Therapies and Technology Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Basic Infusion
1.4.3 Therapeutic Infusion
1.4.4 Nutritious Infusion
1.5 Global Infusion Therapies and Technology Market Size & Forecast
1.6 Global Infusion Therapies and Technology Market Size and Forecast by Region
1.6.1 Global Infusion Therapies and Technology Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Infusion Therapies and Technology Market Size by Region, (2021-2032)
1.6.3 North America Infusion Therapies and Technology Market Size and Prospect (2021-2032)
1.6.4 Europe Infusion Therapies and Technology Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Infusion Therapies and Technology Market Size and Prospect (2021-2032)
1.6.6 South America Infusion Therapies and Technology Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Infusion Therapies and Technology Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Baxter Healthcare
2.1.1 Baxter Healthcare Details
2.1.2 Baxter Healthcare Major Business
2.1.3 Baxter Healthcare Infusion Therapies and Technology Product and Solutions
2.1.4 Baxter Healthcare Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Baxter Healthcare Recent Developments and Future Plans
2.2 Kelun Group
2.2.1 Kelun Group Details
2.2.2 Kelun Group Major Business
2.2.3 Kelun Group Infusion Therapies and Technology Product and Solutions
2.2.4 Kelun Group Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Kelun Group Recent Developments and Future Plans
2.3 Fresenius
2.3.1 Fresenius Details
2.3.2 Fresenius Major Business
2.3.3 Fresenius Infusion Therapies and Technology Product and Solutions
2.3.4 Fresenius Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Fresenius Recent Developments and Future Plans
2.4 B. Braun
2.4.1 B. Braun Details
2.4.2 B. Braun Major Business
2.4.3 B. Braun Infusion Therapies and Technology Product and Solutions
2.4.4 B. Braun Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 B. Braun Recent Developments and Future Plans
2.5 Ostuka Pharmaceutical
2.5.1 Ostuka Pharmaceutical Details
2.5.2 Ostuka Pharmaceutical Major Business
2.5.3 Ostuka Pharmaceutical Infusion Therapies and Technology Product and Solutions
2.5.4 Ostuka Pharmaceutical Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Ostuka Pharmaceutical Recent Developments and Future Plans
2.6 ICU Medical
2.6.1 ICU Medical Details
2.6.2 ICU Medical Major Business
2.6.3 ICU Medical Infusion Therapies and Technology Product and Solutions
2.6.4 ICU Medical Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 ICU Medical Recent Developments and Future Plans
2.7 SSY Group
2.7.1 SSY Group Details
2.7.2 SSY Group Major Business
2.7.3 SSY Group Infusion Therapies and Technology Product and Solutions
2.7.4 SSY Group Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 SSY Group Recent Developments and Future Plans
2.8 Shuang Hor
2.8.1 Shuang Hor Details
2.8.2 Shuang Hor Major Business
2.8.3 Shuang Hor Infusion Therapies and Technology Product and Solutions
2.8.4 Shuang Hor Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Shuang Hor Recent Developments and Future Plans
2.9 Cisen Pharmaceutical
2.9.1 Cisen Pharmaceutical Details
2.9.2 Cisen Pharmaceutical Major Business
2.9.3 Cisen Pharmaceutical Infusion Therapies and Technology Product and Solutions
2.9.4 Cisen Pharmaceutical Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Cisen Pharmaceutical Recent Developments and Future Plans
2.10 PiSA Farmac?utica
2.10.1 PiSA Farmac?utica Details
2.10.2 PiSA Farmac?utica Major Business
2.10.3 PiSA Farmac?utica Infusion Therapies and Technology Product and Solutions
2.10.4 PiSA Farmac?utica Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 PiSA Farmac?utica Recent Developments and Future Plans
2.11 Huaren Pharmaceutical
2.11.1 Huaren Pharmaceutical Details
2.11.2 Huaren Pharmaceutical Major Business
2.11.3 Huaren Pharmaceutical Infusion Therapies and Technology Product and Solutions
2.11.4 Huaren Pharmaceutical Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Huaren Pharmaceutical Recent Developments and Future Plans
2.12 Chimin
2.12.1 Chimin Details
2.12.2 Chimin Major Business
2.12.3 Chimin Infusion Therapies and Technology Product and Solutions
2.12.4 Chimin Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Chimin Recent Developments and Future Plans
2.13 Beximco Pharma
2.13.1 Beximco Pharma Details
2.13.2 Beximco Pharma Major Business
2.13.3 Beximco Pharma Infusion Therapies and Technology Product and Solutions
2.13.4 Beximco Pharma Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Beximco Pharma Recent Developments and Future Plans
2.14 Albert David
2.14.1 Albert David Details
2.14.2 Albert David Major Business
2.14.3 Albert David Infusion Therapies and Technology Product and Solutions
2.14.4 Albert David Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Albert David Recent Developments and Future Plans
2.15 PSI Ltd
2.15.1 PSI Ltd Details
2.15.2 PSI Ltd Major Business
2.15.3 PSI Ltd Infusion Therapies and Technology Product and Solutions
2.15.4 PSI Ltd Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 PSI Ltd Recent Developments and Future Plans
2.16 Ozon Pharmaceuticals
2.16.1 Ozon Pharmaceuticals Details
2.16.2 Ozon Pharmaceuticals Major Business
2.16.3 Ozon Pharmaceuticals Infusion Therapies and Technology Product and Solutions
2.16.4 Ozon Pharmaceuticals Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Ozon Pharmaceuticals Recent Developments and Future Plans
2.17 BML Parenteral Drugs
2.17.1 BML Parenteral Drugs Details
2.17.2 BML Parenteral Drugs Major Business
2.17.3 BML Parenteral Drugs Infusion Therapies and Technology Product and Solutions
2.17.4 BML Parenteral Drugs Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 BML Parenteral Drugs Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Infusion Therapies and Technology Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Infusion Therapies and Technology by Company Revenue
3.2.2 Top 3 Infusion Therapies and Technology Players Market Share in 2025
3.2.3 Top 6 Infusion Therapies and Technology Players Market Share in 2025
3.3 Infusion Therapies and Technology Market: Overall Company Footprint Analysis
3.3.1 Infusion Therapies and Technology Market: Region Footprint
3.3.2 Infusion Therapies and Technology Market: Company Product Type Footprint
3.3.3 Infusion Therapies and Technology Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Infusion Therapies and Technology Consumption Value and Market Share by Type (2021-2026)
4.2 Global Infusion Therapies and Technology Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Infusion Therapies and Technology Consumption Value Market Share by Application (2021-2026)
5.2 Global Infusion Therapies and Technology Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Infusion Therapies and Technology Consumption Value by Type (2021-2032)
6.2 North America Infusion Therapies and Technology Market Size by Application (2021-2032)
6.3 North America Infusion Therapies and Technology Market Size by Country
6.3.1 North America Infusion Therapies and Technology Consumption Value by Country (2021-2032)
6.3.2 United States Infusion Therapies and Technology Market Size and Forecast (2021-2032)
6.3.3 Canada Infusion Therapies and Technology Market Size and Forecast (2021-2032)
6.3.4 Mexico Infusion Therapies and Technology Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Infusion Therapies and Technology Consumption Value by Type (2021-2032)
7.2 Europe Infusion Therapies and Technology Consumption Value by Application (2021-2032)
7.3 Europe Infusion Therapies and Technology Market Size by Country
7.3.1 Europe Infusion Therapies and Technology Consumption Value by Country (2021-2032)
7.3.2 Germany Infusion Therapies and Technology Market Size and Forecast (2021-2032)
7.3.3 France Infusion Therapies and Technology Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Infusion Therapies and Technology Market Size and Forecast (2021-2032)
7.3.5 Russia Infusion Therapies and Technology Market Size and Forecast (2021-2032)
7.3.6 Italy Infusion Therapies and Technology Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Infusion Therapies and Technology Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Infusion Therapies and Technology Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Infusion Therapies and Technology Market Size by Region
8.3.1 Asia-Pacific Infusion Therapies and Technology Consumption Value by Region (2021-2032)
8.3.2 China Infusion Therapies and Technology Market Size and Forecast (2021-2032)
8.3.3 Japan Infusion Therapies and Technology Market Size and Forecast (2021-2032)
8.3.4 South Korea Infusion Therapies and Technology Market Size and Forecast (2021-2032)
8.3.5 India Infusion Therapies and Technology Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Infusion Therapies and Technology Market Size and Forecast (2021-2032)
8.3.7 Australia Infusion Therapies and Technology Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Infusion Therapies and Technology Consumption Value by Type (2021-2032)
9.2 South America Infusion Therapies and Technology Consumption Value by Application (2021-2032)
9.3 South America Infusion Therapies and Technology Market Size by Country
9.3.1 South America Infusion Therapies and Technology Consumption Value by Country (2021-2032)
9.3.2 Brazil Infusion Therapies and Technology Market Size and Forecast (2021-2032)
9.3.3 Argentina Infusion Therapies and Technology Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Infusion Therapies and Technology Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Infusion Therapies and Technology Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Infusion Therapies and Technology Market Size by Country
10.3.1 Middle East & Africa Infusion Therapies and Technology Consumption Value by Country (2021-2032)
10.3.2 Turkey Infusion Therapies and Technology Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Infusion Therapies and Technology Market Size and Forecast (2021-2032)
10.3.4 UAE Infusion Therapies and Technology Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Infusion Therapies and Technology Market Drivers
11.2 Infusion Therapies and Technology Market Restraints
11.3 Infusion Therapies and Technology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Infusion Therapies and Technology Industry Chain
12.2 Infusion Therapies and Technology Upstream Analysis
12.3 Infusion Therapies and Technology Midstream Analysis
12.4 Infusion Therapies and Technology Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Infusion Therapies and Technology by Type
1.3.1 Overview: Global Infusion Therapies and Technology Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Infusion Therapies and Technology Consumption Value Market Share by Type in 2025
1.3.3 Large Volume Intravenous Infusion
1.3.4 Small Volume Intravenous Infusion
1.4 Global Infusion Therapies and Technology Market by Application
1.4.1 Overview: Global Infusion Therapies and Technology Market Size by Application: 2021 Versus 2025 Versus 2032
1.4.2 Basic Infusion
1.4.3 Therapeutic Infusion
1.4.4 Nutritious Infusion
1.5 Global Infusion Therapies and Technology Market Size & Forecast
1.6 Global Infusion Therapies and Technology Market Size and Forecast by Region
1.6.1 Global Infusion Therapies and Technology Market Size by Region: 2021 VS 2025 VS 2032
1.6.2 Global Infusion Therapies and Technology Market Size by Region, (2021-2032)
1.6.3 North America Infusion Therapies and Technology Market Size and Prospect (2021-2032)
1.6.4 Europe Infusion Therapies and Technology Market Size and Prospect (2021-2032)
1.6.5 Asia-Pacific Infusion Therapies and Technology Market Size and Prospect (2021-2032)
1.6.6 South America Infusion Therapies and Technology Market Size and Prospect (2021-2032)
1.6.7 Middle East & Africa Infusion Therapies and Technology Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Baxter Healthcare
2.1.1 Baxter Healthcare Details
2.1.2 Baxter Healthcare Major Business
2.1.3 Baxter Healthcare Infusion Therapies and Technology Product and Solutions
2.1.4 Baxter Healthcare Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Baxter Healthcare Recent Developments and Future Plans
2.2 Kelun Group
2.2.1 Kelun Group Details
2.2.2 Kelun Group Major Business
2.2.3 Kelun Group Infusion Therapies and Technology Product and Solutions
2.2.4 Kelun Group Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Kelun Group Recent Developments and Future Plans
2.3 Fresenius
2.3.1 Fresenius Details
2.3.2 Fresenius Major Business
2.3.3 Fresenius Infusion Therapies and Technology Product and Solutions
2.3.4 Fresenius Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Fresenius Recent Developments and Future Plans
2.4 B. Braun
2.4.1 B. Braun Details
2.4.2 B. Braun Major Business
2.4.3 B. Braun Infusion Therapies and Technology Product and Solutions
2.4.4 B. Braun Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 B. Braun Recent Developments and Future Plans
2.5 Ostuka Pharmaceutical
2.5.1 Ostuka Pharmaceutical Details
2.5.2 Ostuka Pharmaceutical Major Business
2.5.3 Ostuka Pharmaceutical Infusion Therapies and Technology Product and Solutions
2.5.4 Ostuka Pharmaceutical Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Ostuka Pharmaceutical Recent Developments and Future Plans
2.6 ICU Medical
2.6.1 ICU Medical Details
2.6.2 ICU Medical Major Business
2.6.3 ICU Medical Infusion Therapies and Technology Product and Solutions
2.6.4 ICU Medical Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 ICU Medical Recent Developments and Future Plans
2.7 SSY Group
2.7.1 SSY Group Details
2.7.2 SSY Group Major Business
2.7.3 SSY Group Infusion Therapies and Technology Product and Solutions
2.7.4 SSY Group Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 SSY Group Recent Developments and Future Plans
2.8 Shuang Hor
2.8.1 Shuang Hor Details
2.8.2 Shuang Hor Major Business
2.8.3 Shuang Hor Infusion Therapies and Technology Product and Solutions
2.8.4 Shuang Hor Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Shuang Hor Recent Developments and Future Plans
2.9 Cisen Pharmaceutical
2.9.1 Cisen Pharmaceutical Details
2.9.2 Cisen Pharmaceutical Major Business
2.9.3 Cisen Pharmaceutical Infusion Therapies and Technology Product and Solutions
2.9.4 Cisen Pharmaceutical Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Cisen Pharmaceutical Recent Developments and Future Plans
2.10 PiSA Farmac?utica
2.10.1 PiSA Farmac?utica Details
2.10.2 PiSA Farmac?utica Major Business
2.10.3 PiSA Farmac?utica Infusion Therapies and Technology Product and Solutions
2.10.4 PiSA Farmac?utica Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 PiSA Farmac?utica Recent Developments and Future Plans
2.11 Huaren Pharmaceutical
2.11.1 Huaren Pharmaceutical Details
2.11.2 Huaren Pharmaceutical Major Business
2.11.3 Huaren Pharmaceutical Infusion Therapies and Technology Product and Solutions
2.11.4 Huaren Pharmaceutical Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Huaren Pharmaceutical Recent Developments and Future Plans
2.12 Chimin
2.12.1 Chimin Details
2.12.2 Chimin Major Business
2.12.3 Chimin Infusion Therapies and Technology Product and Solutions
2.12.4 Chimin Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Chimin Recent Developments and Future Plans
2.13 Beximco Pharma
2.13.1 Beximco Pharma Details
2.13.2 Beximco Pharma Major Business
2.13.3 Beximco Pharma Infusion Therapies and Technology Product and Solutions
2.13.4 Beximco Pharma Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Beximco Pharma Recent Developments and Future Plans
2.14 Albert David
2.14.1 Albert David Details
2.14.2 Albert David Major Business
2.14.3 Albert David Infusion Therapies and Technology Product and Solutions
2.14.4 Albert David Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Albert David Recent Developments and Future Plans
2.15 PSI Ltd
2.15.1 PSI Ltd Details
2.15.2 PSI Ltd Major Business
2.15.3 PSI Ltd Infusion Therapies and Technology Product and Solutions
2.15.4 PSI Ltd Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 PSI Ltd Recent Developments and Future Plans
2.16 Ozon Pharmaceuticals
2.16.1 Ozon Pharmaceuticals Details
2.16.2 Ozon Pharmaceuticals Major Business
2.16.3 Ozon Pharmaceuticals Infusion Therapies and Technology Product and Solutions
2.16.4 Ozon Pharmaceuticals Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Ozon Pharmaceuticals Recent Developments and Future Plans
2.17 BML Parenteral Drugs
2.17.1 BML Parenteral Drugs Details
2.17.2 BML Parenteral Drugs Major Business
2.17.3 BML Parenteral Drugs Infusion Therapies and Technology Product and Solutions
2.17.4 BML Parenteral Drugs Infusion Therapies and Technology Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 BML Parenteral Drugs Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Infusion Therapies and Technology Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Infusion Therapies and Technology by Company Revenue
3.2.2 Top 3 Infusion Therapies and Technology Players Market Share in 2025
3.2.3 Top 6 Infusion Therapies and Technology Players Market Share in 2025
3.3 Infusion Therapies and Technology Market: Overall Company Footprint Analysis
3.3.1 Infusion Therapies and Technology Market: Region Footprint
3.3.2 Infusion Therapies and Technology Market: Company Product Type Footprint
3.3.3 Infusion Therapies and Technology Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Infusion Therapies and Technology Consumption Value and Market Share by Type (2021-2026)
4.2 Global Infusion Therapies and Technology Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Infusion Therapies and Technology Consumption Value Market Share by Application (2021-2026)
5.2 Global Infusion Therapies and Technology Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Infusion Therapies and Technology Consumption Value by Type (2021-2032)
6.2 North America Infusion Therapies and Technology Market Size by Application (2021-2032)
6.3 North America Infusion Therapies and Technology Market Size by Country
6.3.1 North America Infusion Therapies and Technology Consumption Value by Country (2021-2032)
6.3.2 United States Infusion Therapies and Technology Market Size and Forecast (2021-2032)
6.3.3 Canada Infusion Therapies and Technology Market Size and Forecast (2021-2032)
6.3.4 Mexico Infusion Therapies and Technology Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Infusion Therapies and Technology Consumption Value by Type (2021-2032)
7.2 Europe Infusion Therapies and Technology Consumption Value by Application (2021-2032)
7.3 Europe Infusion Therapies and Technology Market Size by Country
7.3.1 Europe Infusion Therapies and Technology Consumption Value by Country (2021-2032)
7.3.2 Germany Infusion Therapies and Technology Market Size and Forecast (2021-2032)
7.3.3 France Infusion Therapies and Technology Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Infusion Therapies and Technology Market Size and Forecast (2021-2032)
7.3.5 Russia Infusion Therapies and Technology Market Size and Forecast (2021-2032)
7.3.6 Italy Infusion Therapies and Technology Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Infusion Therapies and Technology Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Infusion Therapies and Technology Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Infusion Therapies and Technology Market Size by Region
8.3.1 Asia-Pacific Infusion Therapies and Technology Consumption Value by Region (2021-2032)
8.3.2 China Infusion Therapies and Technology Market Size and Forecast (2021-2032)
8.3.3 Japan Infusion Therapies and Technology Market Size and Forecast (2021-2032)
8.3.4 South Korea Infusion Therapies and Technology Market Size and Forecast (2021-2032)
8.3.5 India Infusion Therapies and Technology Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Infusion Therapies and Technology Market Size and Forecast (2021-2032)
8.3.7 Australia Infusion Therapies and Technology Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Infusion Therapies and Technology Consumption Value by Type (2021-2032)
9.2 South America Infusion Therapies and Technology Consumption Value by Application (2021-2032)
9.3 South America Infusion Therapies and Technology Market Size by Country
9.3.1 South America Infusion Therapies and Technology Consumption Value by Country (2021-2032)
9.3.2 Brazil Infusion Therapies and Technology Market Size and Forecast (2021-2032)
9.3.3 Argentina Infusion Therapies and Technology Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Infusion Therapies and Technology Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Infusion Therapies and Technology Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Infusion Therapies and Technology Market Size by Country
10.3.1 Middle East & Africa Infusion Therapies and Technology Consumption Value by Country (2021-2032)
10.3.2 Turkey Infusion Therapies and Technology Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Infusion Therapies and Technology Market Size and Forecast (2021-2032)
10.3.4 UAE Infusion Therapies and Technology Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Infusion Therapies and Technology Market Drivers
11.2 Infusion Therapies and Technology Market Restraints
11.3 Infusion Therapies and Technology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Infusion Therapies and Technology Industry Chain
12.2 Infusion Therapies and Technology Upstream Analysis
12.3 Infusion Therapies and Technology Midstream Analysis
12.4 Infusion Therapies and Technology Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Infusion Therapies and Technology Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Infusion Therapies and Technology Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Infusion Therapies and Technology Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Infusion Therapies and Technology Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Baxter Healthcare Company Information, Head Office, and Major Competitors
Table 6. Baxter Healthcare Major Business
Table 7. Baxter Healthcare Infusion Therapies and Technology Product and Solutions
Table 8. Baxter Healthcare Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Baxter Healthcare Recent Developments and Future Plans
Table 10. Kelun Group Company Information, Head Office, and Major Competitors
Table 11. Kelun Group Major Business
Table 12. Kelun Group Infusion Therapies and Technology Product and Solutions
Table 13. Kelun Group Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Kelun Group Recent Developments and Future Plans
Table 15. Fresenius Company Information, Head Office, and Major Competitors
Table 16. Fresenius Major Business
Table 17. Fresenius Infusion Therapies and Technology Product and Solutions
Table 18. Fresenius Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. B. Braun Company Information, Head Office, and Major Competitors
Table 20. B. Braun Major Business
Table 21. B. Braun Infusion Therapies and Technology Product and Solutions
Table 22. B. Braun Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. B. Braun Recent Developments and Future Plans
Table 24. Ostuka Pharmaceutical Company Information, Head Office, and Major Competitors
Table 25. Ostuka Pharmaceutical Major Business
Table 26. Ostuka Pharmaceutical Infusion Therapies and Technology Product and Solutions
Table 27. Ostuka Pharmaceutical Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Ostuka Pharmaceutical Recent Developments and Future Plans
Table 29. ICU Medical Company Information, Head Office, and Major Competitors
Table 30. ICU Medical Major Business
Table 31. ICU Medical Infusion Therapies and Technology Product and Solutions
Table 32. ICU Medical Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. ICU Medical Recent Developments and Future Plans
Table 34. SSY Group Company Information, Head Office, and Major Competitors
Table 35. SSY Group Major Business
Table 36. SSY Group Infusion Therapies and Technology Product and Solutions
Table 37. SSY Group Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. SSY Group Recent Developments and Future Plans
Table 39. Shuang Hor Company Information, Head Office, and Major Competitors
Table 40. Shuang Hor Major Business
Table 41. Shuang Hor Infusion Therapies and Technology Product and Solutions
Table 42. Shuang Hor Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Shuang Hor Recent Developments and Future Plans
Table 44. Cisen Pharmaceutical Company Information, Head Office, and Major Competitors
Table 45. Cisen Pharmaceutical Major Business
Table 46. Cisen Pharmaceutical Infusion Therapies and Technology Product and Solutions
Table 47. Cisen Pharmaceutical Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Cisen Pharmaceutical Recent Developments and Future Plans
Table 49. PiSA Farmac?utica Company Information, Head Office, and Major Competitors
Table 50. PiSA Farmac?utica Major Business
Table 51. PiSA Farmac?utica Infusion Therapies and Technology Product and Solutions
Table 52. PiSA Farmac?utica Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. PiSA Farmac?utica Recent Developments and Future Plans
Table 54. Huaren Pharmaceutical Company Information, Head Office, and Major Competitors
Table 55. Huaren Pharmaceutical Major Business
Table 56. Huaren Pharmaceutical Infusion Therapies and Technology Product and Solutions
Table 57. Huaren Pharmaceutical Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Huaren Pharmaceutical Recent Developments and Future Plans
Table 59. Chimin Company Information, Head Office, and Major Competitors
Table 60. Chimin Major Business
Table 61. Chimin Infusion Therapies and Technology Product and Solutions
Table 62. Chimin Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Chimin Recent Developments and Future Plans
Table 64. Beximco Pharma Company Information, Head Office, and Major Competitors
Table 65. Beximco Pharma Major Business
Table 66. Beximco Pharma Infusion Therapies and Technology Product and Solutions
Table 67. Beximco Pharma Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Beximco Pharma Recent Developments and Future Plans
Table 69. Albert David Company Information, Head Office, and Major Competitors
Table 70. Albert David Major Business
Table 71. Albert David Infusion Therapies and Technology Product and Solutions
Table 72. Albert David Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Albert David Recent Developments and Future Plans
Table 74. PSI Ltd Company Information, Head Office, and Major Competitors
Table 75. PSI Ltd Major Business
Table 76. PSI Ltd Infusion Therapies and Technology Product and Solutions
Table 77. PSI Ltd Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. PSI Ltd Recent Developments and Future Plans
Table 79. Ozon Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 80. Ozon Pharmaceuticals Major Business
Table 81. Ozon Pharmaceuticals Infusion Therapies and Technology Product and Solutions
Table 82. Ozon Pharmaceuticals Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Ozon Pharmaceuticals Recent Developments and Future Plans
Table 84. BML Parenteral Drugs Company Information, Head Office, and Major Competitors
Table 85. BML Parenteral Drugs Major Business
Table 86. BML Parenteral Drugs Infusion Therapies and Technology Product and Solutions
Table 87. BML Parenteral Drugs Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 88. BML Parenteral Drugs Recent Developments and Future Plans
Table 89. Global Infusion Therapies and Technology Revenue (USD Million) by Players (2021-2026)
Table 90. Global Infusion Therapies and Technology Revenue Share by Players (2021-2026)
Table 91. Breakdown of Infusion Therapies and Technology by Company Type (Tier 1, Tier 2, and Tier 3)
Table 92. Market Position of Players in Infusion Therapies and Technology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 93. Head Office of Key Infusion Therapies and Technology Players
Table 94. Infusion Therapies and Technology Market: Company Product Type Footprint
Table 95. Infusion Therapies and Technology Market: Company Product Application Footprint
Table 96. Infusion Therapies and Technology New Market Entrants and Barriers to Market Entry
Table 97. Infusion Therapies and Technology Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global Infusion Therapies and Technology Consumption Value (USD Million) by Type (2021-2026)
Table 99. Global Infusion Therapies and Technology Consumption Value Share by Type (2021-2026)
Table 100. Global Infusion Therapies and Technology Consumption Value Forecast by Type (2027-2032)
Table 101. Global Infusion Therapies and Technology Consumption Value by Application (2021-2026)
Table 102. Global Infusion Therapies and Technology Consumption Value Forecast by Application (2027-2032)
Table 103. North America Infusion Therapies and Technology Consumption Value by Type (2021-2026) & (USD Million)
Table 104. North America Infusion Therapies and Technology Consumption Value by Type (2027-2032) & (USD Million)
Table 105. North America Infusion Therapies and Technology Consumption Value by Application (2021-2026) & (USD Million)
Table 106. North America Infusion Therapies and Technology Consumption Value by Application (2027-2032) & (USD Million)
Table 107. North America Infusion Therapies and Technology Consumption Value by Country (2021-2026) & (USD Million)
Table 108. North America Infusion Therapies and Technology Consumption Value by Country (2027-2032) & (USD Million)
Table 109. Europe Infusion Therapies and Technology Consumption Value by Type (2021-2026) & (USD Million)
Table 110. Europe Infusion Therapies and Technology Consumption Value by Type (2027-2032) & (USD Million)
Table 111. Europe Infusion Therapies and Technology Consumption Value by Application (2021-2026) & (USD Million)
Table 112. Europe Infusion Therapies and Technology Consumption Value by Application (2027-2032) & (USD Million)
Table 113. Europe Infusion Therapies and Technology Consumption Value by Country (2021-2026) & (USD Million)
Table 114. Europe Infusion Therapies and Technology Consumption Value by Country (2027-2032) & (USD Million)
Table 115. Asia-Pacific Infusion Therapies and Technology Consumption Value by Type (2021-2026) & (USD Million)
Table 116. Asia-Pacific Infusion Therapies and Technology Consumption Value by Type (2027-2032) & (USD Million)
Table 117. Asia-Pacific Infusion Therapies and Technology Consumption Value by Application (2021-2026) & (USD Million)
Table 118. Asia-Pacific Infusion Therapies and Technology Consumption Value by Application (2027-2032) & (USD Million)
Table 119. Asia-Pacific Infusion Therapies and Technology Consumption Value by Region (2021-2026) & (USD Million)
Table 120. Asia-Pacific Infusion Therapies and Technology Consumption Value by Region (2027-2032) & (USD Million)
Table 121. South America Infusion Therapies and Technology Consumption Value by Type (2021-2026) & (USD Million)
Table 122. South America Infusion Therapies and Technology Consumption Value by Type (2027-2032) & (USD Million)
Table 123. South America Infusion Therapies and Technology Consumption Value by Application (2021-2026) & (USD Million)
Table 124. South America Infusion Therapies and Technology Consumption Value by Application (2027-2032) & (USD Million)
Table 125. South America Infusion Therapies and Technology Consumption Value by Country (2021-2026) & (USD Million)
Table 126. South America Infusion Therapies and Technology Consumption Value by Country (2027-2032) & (USD Million)
Table 127. Middle East & Africa Infusion Therapies and Technology Consumption Value by Type (2021-2026) & (USD Million)
Table 128. Middle East & Africa Infusion Therapies and Technology Consumption Value by Type (2027-2032) & (USD Million)
Table 129. Middle East & Africa Infusion Therapies and Technology Consumption Value by Application (2021-2026) & (USD Million)
Table 130. Middle East & Africa Infusion Therapies and Technology Consumption Value by Application (2027-2032) & (USD Million)
Table 131. Middle East & Africa Infusion Therapies and Technology Consumption Value by Country (2021-2026) & (USD Million)
Table 132. Middle East & Africa Infusion Therapies and Technology Consumption Value by Country (2027-2032) & (USD Million)
Table 133. Global Key Players of Infusion Therapies and Technology Upstream (Raw Materials)
Table 134. Global Infusion Therapies and Technology Typical Customers
Table 1. Global Infusion Therapies and Technology Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Infusion Therapies and Technology Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Global Infusion Therapies and Technology Consumption Value by Region (2021-2026) & (USD Million)
Table 4. Global Infusion Therapies and Technology Consumption Value by Region (2027-2032) & (USD Million)
Table 5. Baxter Healthcare Company Information, Head Office, and Major Competitors
Table 6. Baxter Healthcare Major Business
Table 7. Baxter Healthcare Infusion Therapies and Technology Product and Solutions
Table 8. Baxter Healthcare Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Baxter Healthcare Recent Developments and Future Plans
Table 10. Kelun Group Company Information, Head Office, and Major Competitors
Table 11. Kelun Group Major Business
Table 12. Kelun Group Infusion Therapies and Technology Product and Solutions
Table 13. Kelun Group Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. Kelun Group Recent Developments and Future Plans
Table 15. Fresenius Company Information, Head Office, and Major Competitors
Table 16. Fresenius Major Business
Table 17. Fresenius Infusion Therapies and Technology Product and Solutions
Table 18. Fresenius Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. B. Braun Company Information, Head Office, and Major Competitors
Table 20. B. Braun Major Business
Table 21. B. Braun Infusion Therapies and Technology Product and Solutions
Table 22. B. Braun Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. B. Braun Recent Developments and Future Plans
Table 24. Ostuka Pharmaceutical Company Information, Head Office, and Major Competitors
Table 25. Ostuka Pharmaceutical Major Business
Table 26. Ostuka Pharmaceutical Infusion Therapies and Technology Product and Solutions
Table 27. Ostuka Pharmaceutical Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Ostuka Pharmaceutical Recent Developments and Future Plans
Table 29. ICU Medical Company Information, Head Office, and Major Competitors
Table 30. ICU Medical Major Business
Table 31. ICU Medical Infusion Therapies and Technology Product and Solutions
Table 32. ICU Medical Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. ICU Medical Recent Developments and Future Plans
Table 34. SSY Group Company Information, Head Office, and Major Competitors
Table 35. SSY Group Major Business
Table 36. SSY Group Infusion Therapies and Technology Product and Solutions
Table 37. SSY Group Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. SSY Group Recent Developments and Future Plans
Table 39. Shuang Hor Company Information, Head Office, and Major Competitors
Table 40. Shuang Hor Major Business
Table 41. Shuang Hor Infusion Therapies and Technology Product and Solutions
Table 42. Shuang Hor Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Shuang Hor Recent Developments and Future Plans
Table 44. Cisen Pharmaceutical Company Information, Head Office, and Major Competitors
Table 45. Cisen Pharmaceutical Major Business
Table 46. Cisen Pharmaceutical Infusion Therapies and Technology Product and Solutions
Table 47. Cisen Pharmaceutical Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Cisen Pharmaceutical Recent Developments and Future Plans
Table 49. PiSA Farmac?utica Company Information, Head Office, and Major Competitors
Table 50. PiSA Farmac?utica Major Business
Table 51. PiSA Farmac?utica Infusion Therapies and Technology Product and Solutions
Table 52. PiSA Farmac?utica Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. PiSA Farmac?utica Recent Developments and Future Plans
Table 54. Huaren Pharmaceutical Company Information, Head Office, and Major Competitors
Table 55. Huaren Pharmaceutical Major Business
Table 56. Huaren Pharmaceutical Infusion Therapies and Technology Product and Solutions
Table 57. Huaren Pharmaceutical Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Huaren Pharmaceutical Recent Developments and Future Plans
Table 59. Chimin Company Information, Head Office, and Major Competitors
Table 60. Chimin Major Business
Table 61. Chimin Infusion Therapies and Technology Product and Solutions
Table 62. Chimin Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Chimin Recent Developments and Future Plans
Table 64. Beximco Pharma Company Information, Head Office, and Major Competitors
Table 65. Beximco Pharma Major Business
Table 66. Beximco Pharma Infusion Therapies and Technology Product and Solutions
Table 67. Beximco Pharma Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Beximco Pharma Recent Developments and Future Plans
Table 69. Albert David Company Information, Head Office, and Major Competitors
Table 70. Albert David Major Business
Table 71. Albert David Infusion Therapies and Technology Product and Solutions
Table 72. Albert David Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Albert David Recent Developments and Future Plans
Table 74. PSI Ltd Company Information, Head Office, and Major Competitors
Table 75. PSI Ltd Major Business
Table 76. PSI Ltd Infusion Therapies and Technology Product and Solutions
Table 77. PSI Ltd Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. PSI Ltd Recent Developments and Future Plans
Table 79. Ozon Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 80. Ozon Pharmaceuticals Major Business
Table 81. Ozon Pharmaceuticals Infusion Therapies and Technology Product and Solutions
Table 82. Ozon Pharmaceuticals Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Ozon Pharmaceuticals Recent Developments and Future Plans
Table 84. BML Parenteral Drugs Company Information, Head Office, and Major Competitors
Table 85. BML Parenteral Drugs Major Business
Table 86. BML Parenteral Drugs Infusion Therapies and Technology Product and Solutions
Table 87. BML Parenteral Drugs Infusion Therapies and Technology Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 88. BML Parenteral Drugs Recent Developments and Future Plans
Table 89. Global Infusion Therapies and Technology Revenue (USD Million) by Players (2021-2026)
Table 90. Global Infusion Therapies and Technology Revenue Share by Players (2021-2026)
Table 91. Breakdown of Infusion Therapies and Technology by Company Type (Tier 1, Tier 2, and Tier 3)
Table 92. Market Position of Players in Infusion Therapies and Technology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 93. Head Office of Key Infusion Therapies and Technology Players
Table 94. Infusion Therapies and Technology Market: Company Product Type Footprint
Table 95. Infusion Therapies and Technology Market: Company Product Application Footprint
Table 96. Infusion Therapies and Technology New Market Entrants and Barriers to Market Entry
Table 97. Infusion Therapies and Technology Mergers, Acquisition, Agreements, and Collaborations
Table 98. Global Infusion Therapies and Technology Consumption Value (USD Million) by Type (2021-2026)
Table 99. Global Infusion Therapies and Technology Consumption Value Share by Type (2021-2026)
Table 100. Global Infusion Therapies and Technology Consumption Value Forecast by Type (2027-2032)
Table 101. Global Infusion Therapies and Technology Consumption Value by Application (2021-2026)
Table 102. Global Infusion Therapies and Technology Consumption Value Forecast by Application (2027-2032)
Table 103. North America Infusion Therapies and Technology Consumption Value by Type (2021-2026) & (USD Million)
Table 104. North America Infusion Therapies and Technology Consumption Value by Type (2027-2032) & (USD Million)
Table 105. North America Infusion Therapies and Technology Consumption Value by Application (2021-2026) & (USD Million)
Table 106. North America Infusion Therapies and Technology Consumption Value by Application (2027-2032) & (USD Million)
Table 107. North America Infusion Therapies and Technology Consumption Value by Country (2021-2026) & (USD Million)
Table 108. North America Infusion Therapies and Technology Consumption Value by Country (2027-2032) & (USD Million)
Table 109. Europe Infusion Therapies and Technology Consumption Value by Type (2021-2026) & (USD Million)
Table 110. Europe Infusion Therapies and Technology Consumption Value by Type (2027-2032) & (USD Million)
Table 111. Europe Infusion Therapies and Technology Consumption Value by Application (2021-2026) & (USD Million)
Table 112. Europe Infusion Therapies and Technology Consumption Value by Application (2027-2032) & (USD Million)
Table 113. Europe Infusion Therapies and Technology Consumption Value by Country (2021-2026) & (USD Million)
Table 114. Europe Infusion Therapies and Technology Consumption Value by Country (2027-2032) & (USD Million)
Table 115. Asia-Pacific Infusion Therapies and Technology Consumption Value by Type (2021-2026) & (USD Million)
Table 116. Asia-Pacific Infusion Therapies and Technology Consumption Value by Type (2027-2032) & (USD Million)
Table 117. Asia-Pacific Infusion Therapies and Technology Consumption Value by Application (2021-2026) & (USD Million)
Table 118. Asia-Pacific Infusion Therapies and Technology Consumption Value by Application (2027-2032) & (USD Million)
Table 119. Asia-Pacific Infusion Therapies and Technology Consumption Value by Region (2021-2026) & (USD Million)
Table 120. Asia-Pacific Infusion Therapies and Technology Consumption Value by Region (2027-2032) & (USD Million)
Table 121. South America Infusion Therapies and Technology Consumption Value by Type (2021-2026) & (USD Million)
Table 122. South America Infusion Therapies and Technology Consumption Value by Type (2027-2032) & (USD Million)
Table 123. South America Infusion Therapies and Technology Consumption Value by Application (2021-2026) & (USD Million)
Table 124. South America Infusion Therapies and Technology Consumption Value by Application (2027-2032) & (USD Million)
Table 125. South America Infusion Therapies and Technology Consumption Value by Country (2021-2026) & (USD Million)
Table 126. South America Infusion Therapies and Technology Consumption Value by Country (2027-2032) & (USD Million)
Table 127. Middle East & Africa Infusion Therapies and Technology Consumption Value by Type (2021-2026) & (USD Million)
Table 128. Middle East & Africa Infusion Therapies and Technology Consumption Value by Type (2027-2032) & (USD Million)
Table 129. Middle East & Africa Infusion Therapies and Technology Consumption Value by Application (2021-2026) & (USD Million)
Table 130. Middle East & Africa Infusion Therapies and Technology Consumption Value by Application (2027-2032) & (USD Million)
Table 131. Middle East & Africa Infusion Therapies and Technology Consumption Value by Country (2021-2026) & (USD Million)
Table 132. Middle East & Africa Infusion Therapies and Technology Consumption Value by Country (2027-2032) & (USD Million)
Table 133. Global Key Players of Infusion Therapies and Technology Upstream (Raw Materials)
Table 134. Global Infusion Therapies and Technology Typical Customers
LIST OF FIGURES
Figure 1. Infusion Therapies and Technology Picture
Figure 2. Global Infusion Therapies and Technology Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Infusion Therapies and Technology Consumption Value Market Share by Type in 2025
Figure 4. Large Volume Intravenous Infusion
Figure 5. Small Volume Intravenous Infusion
Figure 6. Global Infusion Therapies and Technology Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Infusion Therapies and Technology Consumption Value Market Share by Application in 2025
Figure 8. Basic Infusion Picture
Figure 9. Therapeutic Infusion Picture
Figure 10. Nutritious Infusion Picture
Figure 11. Global Infusion Therapies and Technology Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Infusion Therapies and Technology Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Market Infusion Therapies and Technology Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 14. Global Infusion Therapies and Technology Consumption Value Market Share by Region (2021-2032)
Figure 15. Global Infusion Therapies and Technology Consumption Value Market Share by Region in 2025
Figure 16. North America Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 17. Europe Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 18. Asia-Pacific Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 19. South America Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 20. Middle East & Africa Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Infusion Therapies and Technology Revenue Share by Players in 2025
Figure 23. Infusion Therapies and Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 24. Market Share of Infusion Therapies and Technology by Player Revenue in 2025
Figure 25. Top 3 Infusion Therapies and Technology Players Market Share in 2025
Figure 26. Top 6 Infusion Therapies and Technology Players Market Share in 2025
Figure 27. Global Infusion Therapies and Technology Consumption Value Share by Type (2021-2026)
Figure 28. Global Infusion Therapies and Technology Market Share Forecast by Type (2027-2032)
Figure 29. Global Infusion Therapies and Technology Consumption Value Share by Application (2021-2026)
Figure 30. Global Infusion Therapies and Technology Market Share Forecast by Application (2027-2032)
Figure 31. North America Infusion Therapies and Technology Consumption Value Market Share by Type (2021-2032)
Figure 32. North America Infusion Therapies and Technology Consumption Value Market Share by Application (2021-2032)
Figure 33. North America Infusion Therapies and Technology Consumption Value Market Share by Country (2021-2032)
Figure 34. United States Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 35. Canada Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 36. Mexico Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 37. Europe Infusion Therapies and Technology Consumption Value Market Share by Type (2021-2032)
Figure 38. Europe Infusion Therapies and Technology Consumption Value Market Share by Application (2021-2032)
Figure 39. Europe Infusion Therapies and Technology Consumption Value Market Share by Country (2021-2032)
Figure 40. Germany Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 41. France Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 42. United Kingdom Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 43. Russia Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 44. Italy Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 45. Asia-Pacific Infusion Therapies and Technology Consumption Value Market Share by Type (2021-2032)
Figure 46. Asia-Pacific Infusion Therapies and Technology Consumption Value Market Share by Application (2021-2032)
Figure 47. Asia-Pacific Infusion Therapies and Technology Consumption Value Market Share by Region (2021-2032)
Figure 48. China Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 49. Japan Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 50. South Korea Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 51. India Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 52. Southeast Asia Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 53. Australia Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 54. South America Infusion Therapies and Technology Consumption Value Market Share by Type (2021-2032)
Figure 55. South America Infusion Therapies and Technology Consumption Value Market Share by Application (2021-2032)
Figure 56. South America Infusion Therapies and Technology Consumption Value Market Share by Country (2021-2032)
Figure 57. Brazil Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 58. Argentina Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 59. Middle East & Africa Infusion Therapies and Technology Consumption Value Market Share by Type (2021-2032)
Figure 60. Middle East & Africa Infusion Therapies and Technology Consumption Value Market Share by Application (2021-2032)
Figure 61. Middle East & Africa Infusion Therapies and Technology Consumption Value Market Share by Country (2021-2032)
Figure 62. Turkey Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 63. Saudi Arabia Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 64. UAE Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 65. Infusion Therapies and Technology Market Drivers
Figure 66. Infusion Therapies and Technology Market Restraints
Figure 67. Infusion Therapies and Technology Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Infusion Therapies and Technology Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Infusion Therapies and Technology Picture
Figure 2. Global Infusion Therapies and Technology Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Infusion Therapies and Technology Consumption Value Market Share by Type in 2025
Figure 4. Large Volume Intravenous Infusion
Figure 5. Small Volume Intravenous Infusion
Figure 6. Global Infusion Therapies and Technology Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Infusion Therapies and Technology Consumption Value Market Share by Application in 2025
Figure 8. Basic Infusion Picture
Figure 9. Therapeutic Infusion Picture
Figure 10. Nutritious Infusion Picture
Figure 11. Global Infusion Therapies and Technology Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Infusion Therapies and Technology Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Market Infusion Therapies and Technology Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 14. Global Infusion Therapies and Technology Consumption Value Market Share by Region (2021-2032)
Figure 15. Global Infusion Therapies and Technology Consumption Value Market Share by Region in 2025
Figure 16. North America Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 17. Europe Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 18. Asia-Pacific Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 19. South America Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 20. Middle East & Africa Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 21. Company Three Recent Developments and Future Plans
Figure 22. Global Infusion Therapies and Technology Revenue Share by Players in 2025
Figure 23. Infusion Therapies and Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 24. Market Share of Infusion Therapies and Technology by Player Revenue in 2025
Figure 25. Top 3 Infusion Therapies and Technology Players Market Share in 2025
Figure 26. Top 6 Infusion Therapies and Technology Players Market Share in 2025
Figure 27. Global Infusion Therapies and Technology Consumption Value Share by Type (2021-2026)
Figure 28. Global Infusion Therapies and Technology Market Share Forecast by Type (2027-2032)
Figure 29. Global Infusion Therapies and Technology Consumption Value Share by Application (2021-2026)
Figure 30. Global Infusion Therapies and Technology Market Share Forecast by Application (2027-2032)
Figure 31. North America Infusion Therapies and Technology Consumption Value Market Share by Type (2021-2032)
Figure 32. North America Infusion Therapies and Technology Consumption Value Market Share by Application (2021-2032)
Figure 33. North America Infusion Therapies and Technology Consumption Value Market Share by Country (2021-2032)
Figure 34. United States Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 35. Canada Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 36. Mexico Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 37. Europe Infusion Therapies and Technology Consumption Value Market Share by Type (2021-2032)
Figure 38. Europe Infusion Therapies and Technology Consumption Value Market Share by Application (2021-2032)
Figure 39. Europe Infusion Therapies and Technology Consumption Value Market Share by Country (2021-2032)
Figure 40. Germany Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 41. France Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 42. United Kingdom Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 43. Russia Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 44. Italy Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 45. Asia-Pacific Infusion Therapies and Technology Consumption Value Market Share by Type (2021-2032)
Figure 46. Asia-Pacific Infusion Therapies and Technology Consumption Value Market Share by Application (2021-2032)
Figure 47. Asia-Pacific Infusion Therapies and Technology Consumption Value Market Share by Region (2021-2032)
Figure 48. China Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 49. Japan Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 50. South Korea Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 51. India Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 52. Southeast Asia Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 53. Australia Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 54. South America Infusion Therapies and Technology Consumption Value Market Share by Type (2021-2032)
Figure 55. South America Infusion Therapies and Technology Consumption Value Market Share by Application (2021-2032)
Figure 56. South America Infusion Therapies and Technology Consumption Value Market Share by Country (2021-2032)
Figure 57. Brazil Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 58. Argentina Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 59. Middle East & Africa Infusion Therapies and Technology Consumption Value Market Share by Type (2021-2032)
Figure 60. Middle East & Africa Infusion Therapies and Technology Consumption Value Market Share by Application (2021-2032)
Figure 61. Middle East & Africa Infusion Therapies and Technology Consumption Value Market Share by Country (2021-2032)
Figure 62. Turkey Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 63. Saudi Arabia Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 64. UAE Infusion Therapies and Technology Consumption Value (2021-2032) & (USD Million)
Figure 65. Infusion Therapies and Technology Market Drivers
Figure 66. Infusion Therapies and Technology Market Restraints
Figure 67. Infusion Therapies and Technology Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Infusion Therapies and Technology Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
